Successfully reported this slideshow.

Valvular heart disease



Loading in …3
1 of 105
1 of 105

More Related Content

Related Books

Free with a 14 day trial from Scribd

See all

Valvular heart disease

  1. 1. Valvular Heart Disease
  2. 2. Rheumatic fever Rheumatic fever (RF) is generally classified as a connective tissue or collagen-vascular disease It is an inflammatory reaction that causes damage to collagen fibrils and to the ground substance of connective tissue Involves multiple organs: primarily the heart, the joints, and the central nervous system Recurrent attacks of RF may cause fibrosis of heart valves, leading to chronic valvular heart disease
  3. 3. Epidemiology Peak incidence ages 5~15 years Rare before age 4 years and after age 40 years The incidence of RF and prevalence of rheumatic heart disease (RHD) are markedly variable in different countries: In developed country, such as the united states, the incidence of RF < 2/100,000 In many developing countries, the incidence of acute RF approaches or exceeds 100/100,000
  4. 4. Etiology and Pathogenesis Multiple factors contribute to the pathogenesis, including β-hemolytic streptococcal pharyngitis and immunological status of the human body Cross immune response between host and streptococcal antigens Streptococcal pharyngitis ↓ Abnormal reaction-autoimmunity disease
  5. 5. Pathology Pathological characters: Exudative and proliferative inflammatory reactions involving connective or collagen tissue Affects primarily the heart, joints, brain, cutaneous and subcutaneous tissues Pathological process : Exudative stage Proliferative stage: Aschoff nodule (pathognomonic) Fibrosis and calcification (scar formation)
  6. 6. Recurrent attacks of RF (rheumatic carditis, valvulitis) → scar formation and deformity of heart valves → chronic RHD Valvular involvement: Mitral valve: 75%~80% Aortic valve: 30% Tricuspid & pulmonary valves: < 5%
  7. 7. Clinical findings 1 、 Major manifestations ① Carditis: pericarditis, cardiomegaly, congestive heart failure, and mitral or aortic regurgitation murmurs ② Migratory polyarthritis: involves large joints lasts 1~5 weeks, subsides without residual deformity prompt response to salicylates or nonsteroidal agents ③ Erythema marginatum: rare ④ Subcutaneous nodules: uncommon ⑤ Chorea: least common, most diagnostic
  8. 8. 2 、 Minor manifestations ① Clinical findings: fever, polyarthralgias ② Laboratory findings Elevated acute phase reactants: ESR (erythrocyte sedimentation rate) CRP (C reactive protein) ③ ECG change: prolonged P-R interval ④ A history of RF Supporting evidence of an antecedent group A streptococcal infection: ① Positive throat culture or rapid streptococcal antigen test ② Elevated or rising titers of antistreptococcal antibodies (anti-streptolysin O and anti-DNase B)
  9. 9. Diagnosis Based on Jones criteria and confirmation of streptococcal infection Guidelines for the diagnosis of initial attacks of RF (Jones criteria, updated 1992) If supported by evidence of preceding group A streptococcal infection, the presence of two major manifestations or of one major and two minor manifestations establishes the diagnosis of acute RF
  10. 10. Treatment General Measures Strict bed rest Medical Measures 1. Control streptococcal infection Penicillin is of choice benzathine penicillin, 1.2 million units im once, or procaine penicillin, 600,000 units im daily, 10 days If allergic to penicillin, erythromycin be given
  11. 11. 2. Antirheumatic therapy (1) Salicylates Of choice in patients with little or no cardiac involvement; Particularly effective in reducing fever and relieving joint pain and swelling Aspirin 0.6~0.9 g / 4h in adults; lower doses in children (2) Corticosteroids Used in patients who do not respond well to adequate doses of salicylates Prednisone 40~60 mg orally daily, tapering over 2 weeks
  12. 12. 3. Treatment of symptoms and complications If heart failure is present, digitalis preparations should be used cautiously because cardiac toxicity may occur with conventional dosages Prevention Primary prevention Early treatment of streptococcal pharyngitis Penicillin or erythromycin Secondary prevention To prevent recurrence of rheumatic activity Long-acting penicillin (benzathine penicillin) 1.2 million units im, every 4 weeks Sulfonamides or erythromycin may be substituted
  13. 13. Mitral stenosis (MS) Etiology Most commonly rheumatic fever ——rheumatic heart disease ( RHD ) Symptoms commence mostly in 2nd~4th decade 2/3 of all patients are female 25% of all patients with RHD have pure MS 40% have combined MS and mitral regurgitation (MR)
  14. 14. Other rare causes Far less frequently, MS is congenital in etiology observed primarily in infants and young children Calcification of mitral annulus (when subvalvular or intravalvular extension is extensive) observed in old patients Very rarely, MS is a complication of carcinoid disease or connective tissue disease (systemic lupus erythematosus, SLE; rheumatoid arthritis)
  15. 15. Pathology Fibrosis, thickening, rigid and calcification of the valve apparatus Rheumatic fever results in four forms of fusion of the mitral valve apparatus leading to stenosis: Commissural, cuspal, chordal, and combined Characteristically, mitral valve cusps fuse at their edges, and fusion of the chordae results in thickening and shortening of these structures
  16. 16. Commissural adherent and fusion ↓ restricted opening of mitral valve ↓ “fish mouth” shape of mitral valve orifice Thickening, fusion and shortening of the chordae or papillary muscles ↓ funnel-shaped change of valve apparatus
  17. 17. Secondary changes : Chronic MS → Dilatation of the left atrium Fibrosis of the atrial wall Development of mural thrombi Hypertrophy and dilation of RV
  18. 18. Hemodynamic changes MS involves mainly LA and RV 1. Effect of MS on left atrioventricular pressure gradient and left atrial pressure (LAP) MVA transvalvular gradient LAP Normal 4 ~ 6cm2 Mild MS > 1.5cm2 5-10mmHg ↑ Moderate 1.0 ~ 1.5cm2 10-20mmHg ↑↑ Severe < 1.0cm2 ≥20mmHg 25mmHg
  19. 19. 2. Effect of elevated LAP on pulmonary circulation The elevated LAP in turn raises pulmonary venous and capillary pressures (PVP, PCP), resulting in exertional dyspnea LAP↑ → PVP↑→ PCP↑→ Dyspnea Lung compliance↓ Pulmonary hypertension results from: 1. Passive backward transmission of the elevated LAP 2. Reactive pulmonary arteriolar constriction, which presumably is triggered by left atrial and pulmonary venous hypertension 3. Organic obliterative changes in the pulmonary vascular bed, which may be considered to be a complication of longstanding and severe MS
  20. 20. 3. Effect of pulmonary hypertension on RV Pulmonary hypertension ↓ RV hypertrophy & dilation ( secondary TR, PR ) ↓ Right ventricular failure
  21. 21. Clinical manifestations Symptoms Onset in patients with moderately severe MS ( MVA < 1.5 cm2 ) Dyspnea: Principal symptom, appears at early stage Precipitated by exertion, fever, AF or pregnancy Exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, acute pulmonary edema Hemoptysis Profuse hemorrhage: rupture of bronchial submucosal varices Blood-stained sputum Pink, frothy sputum Cough occurs frequently respiratory infection, compression of left bronchus Hoarseness (Ortner’s syndrome), less common Compression of left recurrent laryngeal nerve
  22. 22. Physical examination Cardiac signs of MS Changes of heart sounds: Accentuated S1 Opening snap (OS) sharp, follows A2 along left sternal border or at apex Both suggest MV leaflets flexible Marked calcification or thickening of the MV leaflets S1 becomes softer, and OS may disappear probably because of diminished motion of the leaflets
  23. 23. Diastolic murmur of MS A low-pitched, diastolic rumbling murmur, localized at or near apex, with pre-systolic accentuation in patients with sinus rhythm Auscultation of the murmur is facilitated by placing the patient in the left lateral position and auscultate during expiration When the patient is in the left lateral recumbent position, a mid-diastolic or presystolic thrill may be palpable at apex
  24. 24. Cardiac signs secondary to pulmonary hypertension and RV dilation RV pulsation is present at the left parasternal region Accentuated or splitting of P2 may be heard in the second left intercostal space Other signs of pulmonary hypertension: Pulmonic ejection sound, owing to dilation of the PA Graham Steell murmur of PR: a decrescendo diastolic murmur along the left sternal border When RV dilation is companied by TR, a pansystolic murmur may be audible in the 4th or 5th intercostal space in the left parasternal region
  25. 25. Other signs Mitral face: malar flush Signs of right heart failure: Systemic venous hypertension, hepatomegaly, edema, and ascites are all signs of severe MS with elevated pulmonary vascular resistance and right heart failure
  26. 26. Laboratory examination Electrocardiography (ECG) Left atrial enlargement Mitral valve P wave P-wave duration in lead II > 0.12 s Large terminal negative P force in lead V1 Right ventricular hypertrophy Arrhythmia Premature atrial contraction → atrial fibrillation
  27. 27. Radiological findings “Mitral valve heart” Marked enlargement of LA Enlargement of RV Dilatation of PA Pulmonary congestion Interstitial edema (manifested as Kerley B lines)
  28. 28. Echocardiography The most valuable technique for diagnosing MS, and determining its severity M-mode echo : Thickened, calcified leaflets open poorly, close slowly (EF slope↓) The double peaks disappear Both leaflets move anteriorly during early diastole Two-dimensional echo: Fusion, thickening, doming of the valve leaflets, and poor leaflet separation in diastole; mitral orifice area↓
  29. 29. Doppler echo : Most accurate noninvasive technique for quantifying the severity of MS Spectrum Doppler: measure transvalvular gradient, MVA Color Doppler: display high velocity color jet Provide other important information Cardiac chamber size (LA, RV) Left ventricular contractility Pulmonary arterial pressure Other coexisted valvular or congenital abnormalities Mural thrombi
  30. 30. Cardiac catheterization Its value in assessment of patients with MS or suspected MS has been largely superseded by echocardiography If surgery is planned, coronary angiography is performed to ascertain whether or not bypass grafting is indicated in patients at risk of having coexisting coronary artery disease
  31. 31. Diagnosis and differential diagnosis Diagnosis Diastolic rumbling murmur at apex ECG or X ray reveals LA dilatation Confirmed by echocardiography Differential diagnosis Diastolic murmur at apex Increased flow across mitral valve Severe MR Massive left to right shunts ( VSD, PDA ) Hyperdynamic circulation ( hyperthyroid, anemia ) Austin-Flint murmur ( severe AR ) Left atrial myxoma postural change of the murmur other signs of myxoma Graham Steell murmur should be differentiated from aortic regurgitation
  32. 32. Complication Atrial fibrillation Common ↓cardiac output by about 20% LA↑, age↑→ Incidence↑ Acute pulmonary edema Severe Dyspnea and cyanosis; unable to lie on back pink, frothy sputum; both lungs filled with rales Thromboembolism Develop in 20% of patients About 2/3 found in the cerebral vessels Recurrent and multiple Risk factors: AF, LA > 55mm, a history of recent embolism or a low cardiac output
  33. 33. Right ventricular failure Late stage, main cause of death Dyspnea and hemoptysis↓—“protective effect” (RV CO↓→ pulmonary circulation↓→LAP↓; thickening of alveolus & pulmonary capillary walls) Infective endocarditis Occurs less frequently on rigid, thickened, calcified valves and is therefore more common in patients with mild than with severe MS Respiratory infection Common Induce and aggregate heart failure
  34. 34. Management General treatment ① Patients with RHD should receive penicillin prophylaxis to prevent recurrence of RF and prophylaxis for IE Avoid and control anemia and infections ② Asymptomatic patients: avoid strenuous exertion ③ Patients with dyspnea should reduce physical activity, restrict sodium intake, and take oral diuretics
  35. 35. Treatment of complications Profuse hemoptysis Measures designed to reduce pulmonary venous pressure, including sedation, assumption of the upright posture, and aggressive diuresis, are used to treat hemoptysis Acute pulmonary edema Dilate venous system, reduce preload (nitrates) Avoid dilating small artery Digitalis glycosides do not benefit patients with MS and sinus rhythm, but are of great value in slowing the ventricular rate in patients with AF and in the treatment of right-sided HF
  36. 36. Treatment of Arrhythmias AF with rapid ventricular rate: ↓Ventricular rate (70~80 bpm) : Digitalis glycosides ( iv cedilanid, oral digoxin ) β-blockers In patients with mild MS without marked LA dilation who have been in AF less than 6~12 months, elective cardioversion (electrical or pharmacological) should be considered
  37. 37. Prophylactic anticoagulant treatment AF Previous embolic episodes LA thrombus revealed by echocardiography Long term anticoagulant treatment with warfarin is necessary in patients without contraindication Right ventricular failure Restriction of sodium intake Diuretics Nitrates
  38. 38. Indications for relieving stenosis Symptomatic patients with moderate to severe MS (MVA < 1.5 cm2), or evidence of pulmonary hypertension with RV hypertrophy Recurrent systemic emboli despite anticoagulation with moderate or severe stenosis Percutaneous balloon mitral valvuloplasty ( PBMV) Procedure of choice for pure MS with pliable and noncalcific valve
  39. 39. Surgical techniques Open mitral commissurotomy Indication: Patients without significant MR valvular calcification, involvement of chordae and papillary muscle, left atrial thrombus or restenosis Mitral valve replacement Indication: Severe distortion and extensive calcification of the valve and subvalvular apparatus; Associated with significant MR or aortic valve disease
  40. 40. Mitral regurgitation (MR) Etiology Mitral valve apparatus and/or LV structural and functional abnormality RHD: common(1/3); + MS and/ or aortic valve disease Mitral valve prolapse (MVP) myxomatous degeneration, floppy and redundancy Ischemic heart disease (or CAD) papillary muscle dysfunction Mitral annular calcification
  41. 41. Severe dilatation of LV result in dilatation of the mitral annulus and lateral movement of papillary muscle Infective endocarditis valve leaflets destruction, perforation, retraction; valve closure interfered by vegetation Other causes: Rupture of the chordae congenital abnormalities obstructive hypertrophic cardiomyopathy
  42. 42. Hemodynamic changes MR involves mainly LA and LV Chronic MR Compensation: MR→ LV volume↑→LV, LA↑→ LVEDV↑→ SV↑→ CO↑, EF↑ Decompensation: Left HF, LAP and LVEDP↑ → pulmonary congestion, pulmonary hypertension, right HF (hepatomegaly, edema, and ascites) CO↓ Acute MR MR →LA, LV volume↑→LVEDP↑→LAP↑→ ↓ pulmonary congestion, pulmonary edema SV and CO↓
  43. 43. Clinical manifestations Symptoms Chronic MR Mild— no symptom Severe— left-sided heart failure Weakness, fatigue (CO↓) Dyspnea (pulmonary congestion) RHD: symptoms occur late, once present, LV dysfunction is usually irreversible MVP: asymptomatic, or atypical chest pain, palpitation, fatigue; in severe MR, left HF occur at late stage Acute Mild— mild exertional dyspnea Severe— acute left HF, pulmonary edema, or cardiac shock
  44. 44. Physical examination Cardiac impulse at apex Hyperdynamic Displaced laterally, inferiorly (Chronic) Changes of heart sounds S1↓(RHD) or normal (MVP, CAD) S3 (severe MR): prominent Mid or late systolic click ( MVP ) ( Acute: P2↑ , S4 )
  45. 45. Systolic murmur RHD : Pansystolic, blowing, high-pitched murmur maximal at the apex Anterior valve lesion, radiate to the axilla and back Posterior leaflet abnormality, radiate to the base MVP : mid- to late-systolic murmur Dysfunction of papillary muscles: Variable (early, mid, late or holosystolic) Rupture of the chordae: musical (Acute MR: not pansystolic murmur, but lower-pitched, decrescendo, and softer than the murmur of chronic MR )
  46. 46. Laboratory examination ECG Chronic (severe) MR: LA dilation, Atrial fibrillation LV enlargement and non-specific ST-T changes Acute MR: sinus tachycardia Radiological findings Chronic (severe) MR: Cardiomegaly with LA, LV↑; pulmonary congestion, interstitial edema with Kerley B lines (left HF) C-shaped calcification of mitral annulus Acute MR: Normal cardiac silhouette or mild LA dilation overt pulmonary congestion, edema
  47. 47. Echocardiography 1 、 Display anatomy of the mitral valve apparatus Useful in determining the etiology of MR (2D) 2 、 Confirm the existence of MR Doppler (color, spectrum): reveal high-velocity jet into LA during systole Sensitivity~100% Estimate the severity of MR < 4 cm2 Mild ( Color flow jet area ) 4~8 cm2 Moderate > 8 cm2 Severe 3 、 Measure cardiac chamber sizes, evaluate LV function, pulmonary artery pressure, provide data concerning other valvular lesions
  48. 48. Radionuclide angiography and MRI Evaluate LV function Estimate the severity of regurgitation The regurgitant fraction can be estimated from the ratio of LV to RV (LV/RV) stroke volume Cardiac catheterization Confirm the diagnosis of MR and estimate its severity, evaluate cardiac function and pulmonary artery pressure Coronary angiography is performed to determine presence of CAD prior to surgery
  49. 49. Diagnosis Chronic MR Typical systolic murmur at apex associated with enlargement of LA and LV Acute MR Sudden onset of dyspnea Systolic murmur at apex Normal cardiac silhouette, but obvious pulmonary congestion etiology existed Confirmed by Echocardiography
  50. 50. Differential diagnosis Tricuspid regurgitation (TR) SM heard best along the left sternal border augmented during inspiration Ventricular septal defect (VSD) SM loudest at the left sternal border accompanied by a parasternal thrill Systolic ejecting murmur at left sternal border: aortic or pulmonic stenosis hypertrophic obstructive cardiomyopathy Echocardiography
  51. 51. Complication Atrial fibrillation seen frequently in severe cases Infective endocarditis more common than in MS Systemic embolism less common than in MS Heart failure occur early in acute MR but late in chronic MR
  52. 52. Management Chronic MR Medical treatment ① Prevention: same as in MS ② Asymptomatic patients with normal cardiac function : follow-up regularly ③ Management of AF : similar to that in MS (slow ventricular rate, anticoagulation) ④ Treatment of heart failure : restriction of sodium intake, angiotensin-converting enzyme inhibitors (ACEI), diuretics, digitalis glycosides
  53. 53. Surgical treatment Mitral valve replacement Indications ① Severe MR and in functional Class Ⅲ or Ⅳ ② Functional ClassⅡ associated with LV dilation (LVESD > 45mm on echocardiography) ③ Severe MR, progressive deterioration of LVEF↓, LVESD and LVEDD↑ Mitral valve repair Indications MVP Chordal rupture Mitral annulus dilation
  54. 54. Acute MR Principle Reduce pulmonary venous pressure Increase cardiac output Correct etiology Medical treatment Intravenous nitroprusside Intravenous diuretics ACEI and other vasodilators Surgical treatment Mitral valve replacement Mitral valve repair
  55. 55. Aortic stenosis (AS) Etiology RHD Common, + AR and mitral valve disease Degenerative calcific AS Common in the elderly, accompanied by calcification of the mitral annulus Congenital abnormalities Calcific stenosis of congenitally bicuspid aortic valve Congenital aortic stenosis
  56. 56. Hemodynamic changes Normal aortic orifice area (AOA): 3.0~4.0 cm2 AOA ≤1.0cm2, LVSP↑, with significant transvalvular gradient Compensation AS→LV pressure load↑ Concentric LVH→compliance↓→LVEDP↑→LAH Maintain systolic wall stress and CO ↑LVEDV Decompensation LVEDV↑→wall stress↑, myocardial ischemia, fibrosis → left HF
  57. 57. Clinical manifestations Symptoms Cardinal symptoms: dyspnea, angina and syncope 1. Dyspnea: exertional dyspnea orthopnea paroxysmal nocturnal dyspnea acute pulmonary edema (varying degrees of pulmonary venous hypertension) 2. Angina pectoris: occurs frequently in patients with critical AS, >1/3 associated with coronary artery disease
  58. 58. Mechanisms of ischemia : ① Myocardial oxygen consumption↑: LVH, LVSP↑, LVET↑ ② Relative decrease in myocardial capillary density ③ Subendocardial coronary artery compression: LVDP↑ ④ Coronary perfusion pressure↓: AO pressure↓, LVDP↑ Imbalance between myocardial oxygen demand and supply 3. Syncope: typically exertional Arterial pressure↓→ cerebral perfusion↓ Mechanisms: Increase blood flow to exercising muscle without compensatory increase in cardiac output Severe arrhythmias
  59. 59. Physical examination Systolic ejection murmur Blowing, harsh, crescendo-decrescendo Maximal at aortic area (R2 or L3, 4) Transmitted to the neck and apex May be associated with systolic thrill The more severe the AS, the longer the duration of the murmur When the LV fails and the CO falls, the murmur becomes softer or disappear
  60. 60. Heart sound changes S1 normal or soft A2 weak or absent paradoxical splitting of S2 prominent S4 Aortic ejection sound congenital AS or pliable valve AS Other signs Left ventricular heave Systolic and pulse pressures↓ Delayed and diminished carotid pulses
  61. 61. Laboratory examination ECG Severe: LVH and secondary ST-T changes, LA↑ , arrhythmias Radiological findings Normal size or slightly enlarged heart Calcification of the aortic valve Poststenotic dilatation of the ascending aorta Pulmonary congestion
  62. 62. Echocardiography Establish a diagnosis, and determine the severity of AS M-mode and 2D echo Observe aortic valve opening, thickening and calcification Helpful in determining the etiology of AS Also invaluable in detecting associated mitral valve disease and in assessing LV performance, hypertrophy, and dilatation
  63. 63. Doppler echo Allows calculation of the aortic valve gradient Estimate the severity of the stenosis < 30 mmHg Mild AS MPG 30~50 mmHg Moderate AS > 50 mmHg Severe AS Color Doppler flow imaging is helpful in the detection and determination of the severity of any accompanying aortic regurgitation
  64. 64. Cardiac catheterization Determine the severity of AS by measuring systolic LV and aortic pressure simultaneously, and calculating the valve area An average pressure gradient of > 50mmHg or peak pressure gradient of ≥ 70mmHg represent severe AS Coronary angiography is performed in most adults to assess for concomitant coronary disease
  65. 65. Diagnosis and differential diagnosis Diagnosis Typical systolic murmur of AS Associated with AR and/or mitral valve damage——RHD Pure AS: Infants and young children——unicuspid malformation Childhood ~65 years——calcification of bicuspid AV > 65 years——degenerative calcification Confirmed by echocardiography
  66. 66. Differential diagnosis Transmitted murmur ( MR, TR, VSD ) Other LVOT obstructive disease Congenital supravalvular AS Congenital subvalvular AS Hypertrophic obstructive cardiomyopathy
  67. 67. Management Medical treatment  Treatment of Arrhythmias: prevent AF with an antiarrhythmic agent when premature atrial contractions are frequent; when AF does occur, restore sinus rhythm  Treatment of angina pectoris: nitrates  Treatment of heart failure: diuretics must be used with caution; vasodilators should be avoided
  68. 68. Surgical treatment Valve replacement Indications: ① Repeated occurrence of syncope, angina pectoris or significant left heart failure ② Asymptomatic patients with progressive LV dysfunction and/or LV hypertrophy, and very high transvalvular gradient ( > 80mmHg) ③ Severe AS ( AOA≤0.7 cm2 ) Commissural incision under direct vision In children and adolescents with noncalcific severe congenital AS
  69. 69. Percutaneous balloon valvuloplasty Indications Children and adolescents with congenital noncalcific AS Adults with severe calcific AS who are poor candidates for surgery or as an intermediate procedure prior to surgery: ①Patients with cardiogenic shock due to critical AS ②Patients with critical AS who require an urgent noncardiac operation ③Pregnant women with critical AS ④Patients with critical AS who refuse surgical treatment
  70. 70. Aortic regurgitation (AR) Etiology Primary disease of the aortic valves and/ or aortic root
  71. 71. Aortic valve disease ① RHD : most common, about 2/3 + AS and/or mitral valve disease ② Infective endocarditis ③ Congenital deformity: bicuspid valves ④ Myxomatous degeneration of the aortic valve Aortic root dilatation ① Marfan syndrome ② Aortic dissection (involve annulus or leaflets) ③ Syphilitic aortitis
  72. 72. Hemodynamic changes Chronic AR Compensation : AR→LV volume↑→ LV↑, LVEDV↑→ SV↑(CO) Decompensation: LV systolic dysfunction→ LV failure (EF↓, LVESV↑) Acute AR AR →LV volume↑→ LVDP↑→ LAP↑ ↓ ↓ CO↓ pulmonary congestion pulmonary edema
  73. 73. Clinical manifestations Symptoms Chronic AR Asymptomatic for many years Palpitation, precordial discomfort, head pounding (related to SV↑) LV failure (dyspnea, fatigue): occur at late stage Angina pectoris or chest pain: less common Acute AR mild—no symptom severe—Acute LV failure and hypotension (pulmonary edema)
  74. 74. Physical examination Chronic, severe AR ① Peripheral arterial signs: Owing to wide pulse pressure: SBP↑, DBP↓ Water-hammer pulse (rapid rise and fall) “Pistol shot sounds” (booming systolic & diastolic sounds sounds heard over femoral artery) Duroziez’s sign (systolic, diastolic murmur over partially compressed femoral artery) Quincke’s sign (subungual capillary pulsations) de Musset’s sign (head bobs with each heartbeat ) ② Apical impulse: diffuse and forceful, displaced laterally and inferiorly (hyperactive, enlarged LV) ③ Heart sound: An S3 gallop is common with LV failure
  75. 75. ④ Heart murmurs Aortic diastolic murmur: High-pitched, blowing, decrescendo pattern When AR is due to primary valvular disease, the diastolic murmur is best heard along the left sternal border in the 3rd and 4th intercostal spaces However, when it is due mainly to dilatation of the ascending aorta, the murmur is often more readily audible along the right upper sternal border Austin-Flint murmur: apical mid or late diastolic low-pitched murmur: common in severe AR, owing to partial closure of MV by the regurgitant jet
  76. 76. Ejection systolic murmur: common harsh at the base of the heart accompanied by a systolic thrill Acute AR S1 soft or absent , P2↑ , S3 and S4 AR murmur: lower pitched and shorter than that of chronic AR Austin-Flint murmur: brief
  77. 77. Laboratory examination ECG Acute: sinus tachycardia; nonspecific ST-T changes Chronic: LV enlargement and hypertrophy, arrhythmias Radiological findings Acute AR: cardiac size normal or slightly enlarged signs of pulmonary congestion, pulmonary edema Chronic: LV enlargement, associated with dilatation of the ascending aorta Severe, aneurysmal dilatation of the aorta suggests aortic root disease ( Marfan syndrome ) Pulmonary congestion ( LV heart failure )
  78. 78. Echocardiography Confirm diagnosis, estimate severity, identify the cause 2-D echo: Structural changes of the valve leaflets and/or aortic root M mode echo: Diastolic fluttering of the anterior leaflet of the mitral valve is an important echocardiographic finding in AR Serial assessments of LV size and function Doppler echo: Sensitive, accurate noninvasive technique for detecting AR LVOT diastolic regurgitant jet, estimate the severity of AR Cardiac catheterization Quantify the severity of AR Evaluate the coronary and aortic root anatomy
  79. 79. Diagnosis and differential diagnosis Diagnosis Characteristic diastolic murmur associated with peripheral arterial signs, make a diagnosis of AR Combined with other information, etiology is usually found Differential diagnosis Graham Steell murmur (pulmonary hypertension associated with dilatation) Austin-Flint murmur: differentiated from that of MS
  80. 80. Management Chronic AR Medical treatment ① Asymptomatic patients with severe AR and LV dilation: Vasodilators (ACEI, et al) reduce the severity of AR, should be used to prolong the compensated period β-blocker: slow the rate of aortic dilation in Marfan’s ② Patients with HF: Vasodilators (ACEI), diuretics and digitalis glycosides
  81. 81. Surgical treatment Valvular replacement Indications: ① Symptomatic patients ② Asymptomatic patients with LV dysfunction, with persistent or progressive LVESV↑or EF↓at rest Repair or replacement of the root Aortic root disease
  82. 82. Acute AR Medical treatment Principle: reduce pulmonary venous pressure, increase cardiac output, and stabilize hemodynamics Intravenous nitroprusside Diuretics Positive inotropic agent Antibiotics ( active IE ) Surgical treatment Urgently required Valvular replacement or aortic valve repair